Introduction: This study aimed to clarify the relationship between anxiety about the possibility of developing dementia (dementia onset anxiety) and subjective memory impairment in frail older individuals who require long-term care and are experiencing declining cognitive function.
Methods: This study included 30 frail older individuals requiring long-term care who completed the Everyday Memory Checklist (EMC), which was simultaneously performed by an occupational therapist (OT). Individuals were divided into two groups: with and without anxiety about dementia onset. We examined the relationship between the presence of anxiety about dementia onset and assessment scores on EMC by the individuals and by the OT.
Results: Approximately 40% of participants expressed anxiety about developing dementia. No significant differences existed between the two groups in terms of age, sex, number of years of education, number of ongoing medical conditions under treatment, types of oral medications, Mini-Mental State-Japanese scores, and total functional independence measure scores. Self-assessed EMC scores by the individuals showed a significant difference between the two groups ( = 0.012, φ = 0.41), while no significant difference in the OT-assessed EMC scores.
Conclusion: Despite similar levels of objective cognitive decline and objective everyday memory impairment, individuals with anxiety about developing dementia have more severe subjective memory impairment than those without such anxiety.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731900 | PMC |
http://dx.doi.org/10.1159/000542445 | DOI Listing |
Dement Geriatr Cogn Dis Extra
December 2024
Department of Rehabilitation, Faculty of Health Sciences, Tokyo Kasei University, Saitama, Japan.
Introduction: This study aimed to clarify the relationship between anxiety about the possibility of developing dementia (dementia onset anxiety) and subjective memory impairment in frail older individuals who require long-term care and are experiencing declining cognitive function.
Methods: This study included 30 frail older individuals requiring long-term care who completed the Everyday Memory Checklist (EMC), which was simultaneously performed by an occupational therapist (OT). Individuals were divided into two groups: with and without anxiety about dementia onset.
Brain Commun
January 2025
Neuromuscular Department, Motor Neuron Disease Centre, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
Neuroinflammation impacts on the progression of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder. Specialized pro-resolving mediators trigger the resolution of inflammation. We investigate the specialized pro-resolving mediator blood profile and their receptors' expression in peripheral blood mononuclear cells in relation to survival in ALS.
View Article and Find Full Text PDFJ Prev Alzheimers Dis
January 2025
Department of Neurology, National Health Insurance Service Ilsan Hospital, Goyang, South Korea. Electronic address:
Background: Early-onset dementia (EOD) and late-onset dementia (LOD) may have distinct modifiable risk-factor profiles.
Objective: To identify and compare factors associated with EOD and LOD using a nationwide cohort database.
Design: Nationwide two nested case-control studies.
Sci Transl Med
January 2025
Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder. Antiamyloid antibody treatments modestly slow disease progression in mild dementia due to AD. Emerging evidence shows that homeostatic dysregulation of the brain immune system, especially that orchestrated by microglia, plays an important role in disease onset and progression.
View Article and Find Full Text PDFBrain
January 2025
U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Neuropresage Team; INSERM, University of Caen Normandy; GIP Cyceron, 14000 Caen, France.
Curing Alzheimer's disease remains hampered by an incomplete understanding of its pathophysiology and progression. Exploring dysfunction in medial temporal lobe networks, particularly the anterior-temporal (AT) and posterior-medial (PM) systems, may provide key insights, as these networks exhibit functional connectivity alterations along the entire Alzheimer's continuum, potentially influencing disease propagation. However, the specific changes in each network and their clinical relevance across stages are not yet fully understood.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!